Also part of the UPMC family:
Also part of the UPMC family:

Cancer Treatment at the McGowan Institute

Why do so many cancers come back after aggressive medical treatments? Could radiation and chemotherapy be targeting the wrong cells? McGowan Institute for Regenerative Medicine cancer researchers have found that some cancer cells are churned out by their own diabolical kind of stem cells.

Modern chemotherapy is based on the idea that you can kill cancer by attacking rapidly dividing cells that are cancer's hallmark. But stem cells don't divide rapidly. They slowly spin off new generations of cells, and these are the fast reproducers. By killing the progeny of stem cells, chemotherapy may be destroying the bulk of the tumor while leaving the stem cells relatively unharmed — and still churning out tumor-building descendants. The following are select examples of projects within the McGowan Institute that are directed toward cancer-related treatments:

McGowan Institute for Regenerative Medicine affiliated faculty members Albert Donnenberg, PhD, and Vera Donnenberg, PhD, are on a quest to find, and eventually kill or manipulate, dormant cancer stem cells. Research by the Donnenbergs has led to the identification and characterization of specific cancer stem cells as well as the development of new flow cytometry-based tools and techniques.

Surgery, a crucial therapeutic modality in the treatment of solid tumors, can induce sterile inflammatory processes which can result in metastatic progression. Liver ischemia and reperfusion (I/R) injury has been shown to foster the liver’s capture of circulating cancer cells and accelerate metastatic growth. Efforts to reduce these negative consequences have not been thoroughly investigated.

However, in the laboratory of McGowan Institute faculty member Marina Kameneva, PhD, her work with drag reducing polymers (DRPs), blood-soluble macromolecules, has shown to reduce the inflammatory microenvironment. DRPs significantly weakened metastatic tumor development and growth in pre-clinical studies. Dr. Kameneva’s further investigation of DRPs as a potential treatment for liver I/R injury in the clinical setting aims to improve cancer-specific outcomes.

Learn how DRPs may improve cancer-specific outcomes in the liver.

Research in the laboratory of McGowan Institute faculty member Eric Lagasse, PharmD, PhD, could lead to new insights into the development and treatment of esophageal cancer and the precancerous condition known as Barrett’s esophagus. In preclinical studies, Dr. Lagasse and his team found a small population of cells that divide more slowly, are more primitive, can generate specialized or differentiated cells, and have the ability to self-renew, which is a defining trait of stem cells. This discovery could lead to new models to study esophageal disease.

Learn more about the discovery of stem cells in the esophagus.

SkinJect, Inc., a Pittsburgh-based company, licensed with the University of Pittsburgh its novel, minimally invasive treatment for common forms of non-melanoma skin cancer, basal cell and squamous cell carcinoma. Two million new cases of basal cell cancer are reported each year in the United States, and more than half of all patients suffer a recurrence. The new product under development could dramatically change the way these skin cancers are treated. The SkinJect™ patch is a thumb-sized array of dissolvable microneedles that will deliver a chemotherapeutic agent to kill an existing skin cancer. The SkinJect patch will be applied once a week, for 3 weeks, in the doctor’s office. The microneedles, less than a millimeter long, dissolve within 15 minutes of application. McGowan Institute affiliated faculty member Louis D. Falo, MD, PhD, is a co-inventor of the microneedle patch.

Learn more about the SkinJect patch.

In support of post-cancer treatment concerns, stem cells derived from a patient's own fat have been studied as a resource in breast reconstruction after cancer surgery by McGowan Institute faculty member J. Peter Rubin, MD.

McGowan Institute for Regenerative Medicine affiliated faculty members Louis D. Falo, MD, PhD, and Valerian Kagan, PhD, DSc, have demonstrated that a newly developed topical therapy applied before or after radiation exposure prevents skin damage in both animal and human models.

Learn more about topical therapy for radiation-induced skin damage.

As the third-leading cause of cancer deaths in the United States, and with a 5-year survival rate of just 8 percent, pancreatic cancer is one of the most lethal forms of the disease. Currently available treatments are largely ineffective, so there is a desperate need for better therapeutic options. In the laboratory of McGowan Institute affiliated faculty member Nathan Bahary, MD, PhD, researchers are paving the way for genome-targeted treatments in pancreatic cancer.

Statistics at a Glance: The Burden of Cancer in the United States

  • In 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States and 595,690 people will die from the disease.
  • The most common cancers in 2016 are projected to be breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, bladder cancer, melanoma of the skin, non-Hodgkin lymphoma, thyroid cancer, kidney and renal pelvis cancer, leukemia, endometrial cancer, and pancreatic cancer.
  • The number of people living beyond a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024.
  • Approximately 39.6% of men and women will be diagnosed with cancer at some point during their lifetimes (based on 2010-2012 data).
  • National expenditures for cancer care in the United States totaled nearly $125 billion in 2010 and could reach $156 billion in 2020.

Read more about cancer statistics from the National Cancer Institute.

Find a Doctor

Browse UPMC doctors and medical professionals to find the care that's right for you. Customize your search by specialty, zip code, last name, and more.


Visit the UPMC Find a Doctor website.
Make an Appointment

Find important information on scheduling your appointment or finding a doctor or service that meets your needs.


Request an appointment now.
Find a Location

Browse addresses and contact information for our network of hospitals, specialty care practices, and community health locations.


Find a UPMC location near you.
Pay Your Bill

Learn more about how to pay your UPMC bill. Find resources including payment methods and contact information for assistance.


Pay your bill now.
Find a Job

Advance your career with UPMC. Discover our latest job listings and learn about our values and career pathways.


Find your ideal job at UPMC.